International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-2 doi: 10.5281/zenodo.14986523
Original Research Article
To study the transactional analysis in well-controlled and poorly controlled Type 2 Diabetes Mellitus: An observational, cross-sectional, pilot study
Published
March 20, 2025
Abstract

Aim and Objective:To evaluate the role of transactional analysis in Type 2 Diabetes Mellitus (T2DM) control using a validated transactional analysis questionnaire and assess the effect of personality type on diabetes management.

Materials and Method:This observational, cross-sectional study was conducted in a tertiary care hospital on T2DM patients (18–60 years) with a disease duration of over one year. Patients were classified as well-controlled or poorly controlled based on HbA1c levels (last three months) or recent medication changes (last month). A validated 36-item transactional analysis questionnaire identified personality types: Nurturing Parent, Critical Parent, Adult, Free Child, and Adopted Child.

Results and Discussion:Among 52 participants (24 males, 28 females, mean age 54 years), 25 were in the well-controlled and 27 in the poorly controlled group. The Nurturing Parent personality type was observed in 22 participants, 14 of whom had well-controlled diabetes. The reliability of the Nurturing Parent scale (Cronbach’s alpha = 0.654) supported its consistency. Conversely, 9 participants exhibited an Adopted Child personality, with 7 belonging to the poorly controlled group.

Conclusion:Nurturing Parent personality was associated with better diabetes control, while Adopted Child personality correlated with poor control. A concise eight-item questionnaire may help predict diabetes management outcomes in future assessments.

Recommended Articles
Loading Image...
Volume-6, Issue-2
Citations
1521 Views
461 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved